20/20 Biolabs revenue was $2.00M for the trailing 12 months ending Sep 30, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2026) ending on Sep 30, 2026 was $380.2k, down 48% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, AIDX annual revenue was $2.0M, with 16.7% growth year-over-year.
AIDX past revenue growth
How has AIDX's revenue growth performed historically?
On Nov 16, 2026, 20/20 Biolabs (NASDAQ: AIDX) reported Q3 2026 revenue of $380.22 thousand up 9.03% year over year. In the same quarter last year, 20/20 Biolabs's revenue was $417.98 thousand.
What was 20/20 Biolabs's revenue in 2025?
20/20 Biolabs's annual revenue for the twelve months ending Dec 31, 2025 was $2.05 million, a 16.71% increase year over year.
How much does 20/20 Biolabs make in a day?
Based on 20/20 Biolabs annual revenue for the past two years, AIDX makes an average of $5,202.02 per day.
What was 20/20 Biolabs's annual revenue growth in the past year?
As of Q4 2026, 20/20 Biolabs's revenue has grown -1.98% year over year. This is 13.03 percentage points lower than the US Medical Devices industry revenue growth rate of 11.05%. 20/20 Biolabs's revenue in the past year totaled $2.00 million.
How much does 20/20 Biolabs make in a year?
20/20 Biolabs's revenue by year for the past two years is:
20/20 Biolabs's revenue for the twelve months ending Dec 31, 2025 was $2.05 million, a 16.71% increase year over year.
20/20 Biolabs's annual revenue for Dec 31, 2024 was $1.75 million, a 23.03% increase from 2023.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.